News

Wednesday, November 06, 2019

First-Year University of Maryland School of Medicine Medical Students Celebrate White Coat Ceremony

The University of Maryland School of Medicine (UMSOM) held its annual White Coat Ceremony on November 1 at the Hippodrome Theatre in downtown Baltimore.


Monday, November 04, 2019

UM School of Medicine has New Requirement for Students: Culinary Medicine

First- and second-year medical students at the University of Maryland School of Medicine (UMSOM) have a new requirement this year in order to earn their medical degree: culinary medicine. Among the first medical schools in the nation to implement the required course, UMSOM aims to increase future physicians’ nutrition knowledge through a class that combines didactic lectures on the evidence supporting many different approaches to healthy eating with experiential techniques that involve the proper chopping of onions, sautéing of vegetables, and garnishing of freshly baked salmon.


Monday, November 04, 2019

UM School of Medicine Set to Host Annual Conference on Advancing School Mental Health

The National Center for School Mental Health at the University of Maryland School of Medicine (UMSOM) will host its 24th Annual Conference on Advancing School Mental Health in Austin, TX on November 7-9, 2019. This year’s theme focuses on teaching evidence-based programs that help children feel safer and more supported in schools, while highlighting the important role schools play in addressing child and adolescent mental health and well-being.


Wednesday, October 30, 2019

UM School of Medicine's Myron M. Levine, MD, DTPH, to Receive Prestigious Lifetime Award for Five Decades of Pioneering Vaccine Research

Myron M. Levine, MD, DTPH, the Simon and Bessie Grollman Distinguished Professor at the University of Maryland School of Medicine (UMSOM), Associate Dean for Global Health, Vaccinology and Infectious Diseases, and Founder and Former Director of the Center for Vaccine Development and Global Health (CVD) is a co-recipient of the 2020 Research! America Geoffrey Beene Foundation Builders of Science Award for his pioneering vaccine and infectious disease research.


Tuesday, October 22, 2019

UMB’s 2019 Founders Week - Public Servant of the Year Awarded to Michelle G. Giglio, PhD

Giglio, is an associate professor in the Department of Medicine and the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM).


Monday, October 21, 2019

UM School of Medicine's Kathleen M Neuzil Elected as Member of Prestigious National Academy of Medicine

Kathleen M. Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM), has been elected as a member of the National Academy of Medicine (NAM), in recognition of her pivotal research that has informed and shaped global vaccine and public health policy. Her membership was announced at the annual NAM meeting in Washington, D.C., placing her among the 2,178 U.S. members of this important organization. Membership in the Academy is considered one of the highest honors for individuals who have made major contributions to the advancement of the medical sciences, health care and public health.


Friday, October 18, 2019

Diabetes Worsens Respiratory Illness Due to Abnormal Immune Response, UM School of Medicine Study Finds

Since the Middle East respiratory syndrome coronavirus (MERS-CoV) first emerged in Saudi Arabia in 2012, there have been more than 2,400 confirmed cases of the infection, resulting in greater than 800 deaths – an alarming fatality rate of 35 percent. For this reason, researchers have been eager to identify any risk factors that contribute to the development of severe or lethal disease. Current clinical evidence points to diabetes as a major risk factor in addition to other comorbidities including kidney disease, heart disease, and lung disease.ndary prevention of serious fractures impacting mobility, such as spinal and hip fractures.


Friday, October 18, 2019

UMSOM Mourns "Passionate Advocate" Rep. Elijah Cummings

The University of Maryland School of Medicine (UMSOM) mourns the loss of Rep. Elijah Cummings from Maryland’s 7th District.


Wednesday, October 16, 2019

Researchers Discover Potential Therapy to Treat Detrimental Effects of Marijuana in Pre-Adolescent Individuals Exposed to THC in Womb

As a growing number of U.S. states legalize the medicinal and recreational use of marijuana, an increasing number of American women are using cannabis before becoming pregnant and during early pregnancy often to treat morning sickness, anxiety, and lower back pain. Although emerging evidence indicates that this may have long-term consequences for their babies’ brain development, how this occurs remains unclear.


Tuesday, October 15, 2019

Theme of 'Courage, Hope and Faith' Highlights Investiture of Dr. Charles Hong as the Melvin Sharoky, MD, Professor of Medicine

In a moving address to an audience of family members, UMSOM faculty and staff, and distinguished invited guests, Charles Hong, MD, PhD, echoed a theme that was heard throughout the ceremony of his investiture as the Melvin Sharoky, MD, Professor of Medicine: “Courage, Hope and Faith.”


Monday, October 14, 2019

In Memoriam: Dr. Kathirkamanathan Shanmuganathan (K. Shan) of the University of Maryland School of Medicine, Professor of Diagnostic Radiology

Shanmuganathan (Shan), who earned his medical degree at the University of Sri Lanka, has been with the University of Maryland School of Medicine for over twenty-five years, and has held the position of Professor of Diagnostic Radiology since 2003.


Friday, October 11, 2019

Invention of the Year: University of Maryland School of Medicine’s kidney delivery by drone

The partnership behind the flight included a collaboration between Dr. Joseph Scalea of University of Maryland School of Medicine and UMD’s A. James Clark School of Engineering, surgeons and researchers at UMMC, the Living Legacy Foundation and AiRXOS.


Friday, October 11, 2019

New Treatment Combination Could Work Against Broader Array of Cancer Cells, Study Finds

In continuing efforts to find novel ways to kill cancer cells, researchers at the University of Maryland School of Medicine (UMSOM) have identified a new pathway that leads to the destruction of cancer cells. The new finding, published this week in the journal PNAS, could pave the way for the broader use of a class of anticancer drugs already on the market. These drugs, known as PARP inhibitors, are currently approved by the FDA to treat only a limited group of breast and ovarian cancers associated with BRCA gene mutations.


Thursday, October 10, 2019

UM School of Medicine Researchers Announce Promising Early Results from Immunotherapy Study on High-Risk Soft Tissue Sarcoma

A combination of two immunotherapy drugs and radiation prior to surgery could offer a potential new treatment for soft tissue sarcomas, a rare type of cancer, according to University of Maryland School of Medicine (UMSOM) researchers who presented their early results this week at the annual Musculoskeletal Tumor Society (MSTS) meeting in Portland, OR.


Tuesday, October 08, 2019

Experimental Growth Factor Shows Promise for Preventing Progression of Knee Osteoarthritis, Study Finds

More than 10 percent of Americans over age 60 experience knee pain related to osteoarthritis, the most common disease of the knee joint. Osteoarthritis of the knee causes pain, activity limitation, physical disability, reduced health-related quality of life and excess mortality compared with the general population. The pain is usually treated with over-the-counter pain relievers, anti-inflammatory drugs, local steroid injections and sometimes surgery. There are currently no drugs approved to treat the underlying cause of the condition, which results from the breakdown of joint cartilage covering the long bones due to increasing age, injury/overuse, obesity, genetics and/or local inflammation. A new experimental growth factor therapy, however, appears to prevent a worsening of osteoarthritis by increasing the thickness of cartilage in the knee joint and preventing further loss, according to results from an early clinical trial that were published today in the Journal of the American Medical Association.


Friday, October 04, 2019

Institute of Human Virology Hosts 21st Annual International Meeting of Top Scientists on Ending the HIV/AIDS Epidemic in America and the Intersection of Opioid Use Disorder

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine commenced IHV2019 held Thursday, October 3 through Friday, October 4 at the Four Seasons Hotel in Baltimore, Maryland. This year “Progress in HIV/AIDS: Challenges in 2020” opened with highlights about the recent plan for "Ending the HIV Epidemic by 2030” with expert opinions by ADM Brett Giroir, MD, Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS)


Friday, October 04, 2019

Dr. Thomas S. Monahan III, University of Maryland School of Medicine Surgeon who Worked with the Needy, Dies

Dr. Thomas S. Monahan III, an academic vascular surgeon at the University of Maryland School of Medicine and a vascular surgeon at the University of Maryland Medical Center who worked tirelessly to bring surgical care to the poor, incarcerated, veterans, uninsured and the mostly forgotten, died Sept. 12 from heart failure at his Baltimore home. He was 44.


Wednesday, October 02, 2019

UM School of Medicine Scientist Tests New CDC Measures to Control Nursing Home Infections

The Centers for Disease Control and Prevention estimates that more than two million people are infected with antibiotic-resistant organisms, resulting in approximately 23,000 deaths annually. Many of these infections spread in nursing homes and long-term rehabilitation facilities, and the CDC issued new guidance in July on the use of personal protective equipment (masks, gowns) by healthcare providers to protect patients in these facilities from acquiring and spreading antibiotic-resistant germs to others. The guidance recommends that workers be required to don a gown and gloves during high-contact activities like wound care, bathing, assisting with toileting, adjusting invasive devices like urinary catheters, or changing dirty bed linens.


Tuesday, October 01, 2019

UM School of Medicine Scientist Receives Prestigious NIH Director's New Innovator Award

Alexandros Poulopoulos, PhD, Assistant Professor in the Department of Pharmacology at the University of Maryland School of Medicine (UMSOM), has received the National Institutes of Health (NIH) Director’s New Innovator Award. The award provides $2.3 million to support an “exceptionally creative early career investigator” as part of The High-Risk, High-Reward Research Program of the NIH Common Fund. The award is reserved for scientists at the beginning of their independent research careers, before receiving other research program funding from the NIH.


Monday, September 30, 2019

Brain & Behavior Research Foundation Announces Dr. William T. Carpenter, Jr. as the Recipient of the 2019 Pardes Humanitarian Prize in Mental Health

The Brain & Behavior Research Foundation today announced that William T. Carpenter, Jr., M.D., Professor of Psychiatry and Pharmacology at Maryland Psychiatric Research Center, Department of Psychiatry, the University of Maryland School of Medicine, is the recipient of the 2019 Pardes Humanitarian Prize in Mental Health. The award will be presented on Friday, November 1, in New York City.


Wednesday, September 25, 2019

UM School of Medicine Scientist Receives NIH Award to Study Heart Disease Related to Down Syndrome

The National Institutes of Health announced today that Zhe Han, PhD, Associate Professor in the Department of Medicine at the University of Maryland School of Medicine (UMSOM), will be awarded a supplemental funding of $772,500 to the ongoing $1.75 million NIH-funded project in Dr. Han’s lab for studying genes involved in Congenital Heart Disease. This supplemental fund will support the research to identify the genetic causes of Congenital Heart Disease that occur in half of all patients with Down syndrome. The goal is to identify genes associated with Down syndrome congenital heart disease and to study the molecular mechanism underlying the cardiac defects. This can potentially lead to better treatments for these heart abnormalities which are a major cause of mortality in those with Down syndrome.

Leave a Reply

Your email address will not be published. Required fields are marked *